Frontiers

HBc: the multifunctional architect of HBV replication, immune evasion, and therapeutic innovation

The hepatitis B core protein (HBc) is a multifunctional viral protein central to hepatitis B virus (HBV) replication, immune modulation, and capsid assembly. Structurally, HBc consists of an ...

Health Check: Genetic Signatures holds course as Island climbs on FDA breakthrough

The board of molecular diagnostics house Genetic Signatures (ASX:GSS) has acknowledged that US sales of its key ...
eLife

Nanoscopy Reveals Heparan Sulfate Clusters as Docking Sites for SARS-CoV-2 Attachment and Entry

Virus entry is thought to involve binding a unique receptor for cell attachment and cytosolic entry. For SARS-CoV-2 underlying the COVID-19 pandemic, angiotensin- converting enzyme 2 (ACE2) is widely ...
The Manila Times

Cocrystal Pharma Reports Third Quarter 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs

Received FDA IND clearance to evaluate CDI-988 as both norovirus preventive and treatmentExpects to initiate CDI-988 Phase 1b ...
Gut

Engineered virus-hunter vaccine overcomes HBV immune tolerance

Background Globally, an estimated 296 million individuals live with chronic hepatitis B virus (HBV) infection, carrying ...
manilatimes

Atea Pharmaceuticals Presents New Data Supporting the Fixed-Dose Combination of Bemnifosbuvir and Ruzasvir as a Potential Best-in-Class Regimen for Treatment of Hepatitis C ...

BOSTON, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral ...
Hosted on MSN

8 Resources That Can Help You Afford Hepatitis C Treatment

The direct-acting antivirals (DAA) for hepatitis C are almost 100 percent effective at curing the infection. Yet only about 1 in 3 people are treated with it in the first year after diagnosis. One ...